IPO GMP Bought All Three Listings Wrong Today: Why Did It Fail? – IPO Guru

Three mainboard IPOs listed at the moment, 1 September 2026. All three had closed on 27 August. The gray market had a quantity prepared for each, and it was mistaken on all three – mistaken on course for 2, mistaken on dimension for all three, and mistaken even on which one would do greatest.

How mistaken was the GMP?

GMP, or gray market premium, is an unofficial worth at which IPO functions and allotted shares change fingers earlier than itemizing. It will not be an change worth and no person ensures it. Here is what it promised at the moment, and what the market really gave.

Listing costs from listing-day reviews dated 1 September 2026. GMP percentages from IPO Guru’s closing readings for points closed 27 August 2026. BSE opens: Skyways ₹124.50, Symbiotec ₹978.20 (a 0.99% low cost), Hy-Tech ₹72 (a 35.85% premium).

Read the final column first. Even Hy-Tech, the one which listed at a powerful premium, got here in 24.5 proportion factors under what the gray market had priced. Somebody anticipating ₹88 obtained ₹75. Still day – however not the day the quantity promised.

The larger miss is the order. GMP mentioned Skyways (23.19%) would beat Symbiotec (18.72%). The market mentioned the alternative: Symbiotec listed flat, Skyways listed 10% under challenge worth. So GMP didn’t simply get the scale mistaken. It obtained the rating mistaken too.

Skyways is the actual shock. A ₹32 premium on a ₹138 challenge meant a 23% pop; as a substitute the inventory opened 10% under challenge worth, a swing of 33 proportion factors. And that is no unknown firm. Skyways began in 1984 and has been ranked the primary air freight forwarder by World ACD for 4 years operating, 2022 to 2025. The full bid and itemizing document is on the Skyways Air Services IPO web page.

Why GMP goes mistaken so usually

The gray market is a small, unregulated market run by a handful of sellers in just a few buying and selling centres. Volumes are skinny, so two or three trades transfer the quote. Two issues comply with from that.

It measures demand, not provide. GMP tells you ways badly folks needed the shares earlier than itemizing. It says nothing about what number of of these shares get bought within the first ten minutes of buying and selling. If an enormous a part of the allotment went to folks planning to exit on day one, the opening worth takes that hit – regardless of the premium mentioned final night.

It stops updating, however the market doesn’t. The final GMP comes the night earlier than itemizing. Overnight, sector information, index strikes and world cues all land. GMP doesn’t modify; the change worth does. That is why each studying on our stay IPO GMP tracker carries a timestamp. A GMP with out a time on it means little or no.

Total subscription additionally failed. QIB didn’t.

Many folks use subscription numbers as a second verify alongside GMP. We have in contrast IPO GMP towards subscription knowledge at size earlier than. Today the headline quantity failed fully – however one a part of it held up.

Final subscription figures for all three points, closed 27 August 2026, from IPO Guru’s subscription knowledge. Listing costs on NSE, 1 September 2026.

Skyways and Symbiotec completed virtually degree on whole subscription – 71.25 instances and 71.26 instances. One listed flat, the opposite 10.14% down. The whole instructed you nothing about which was which.

QIB did. Sort by institutional demand: Hy-Tech (255.77x), Symbiotec (172.03x), Skyways (139.69x). Sort by itemizing acquire: Hy-Tech (+41.51%), Symbiotec (0.00%), Skyways (−10.14%). Same order each instances.

One warning, and it issues as a lot because the discovering. Three knowledge factors falling in the identical order can occur by probability roughly one time in six. This is at some point’s remark, not a examined relationship, and no person ought to construct a rule out of it. The safer level is narrower: the headline a number of mixes classes that behave very in a different way, and studying them individually prices nothing.

Retail tells a 3rd story. Hy-Tech drew 170.58 instances from retail, towards 25.40 instances for Skyways and 12.96 instances for Symbiotec. That separates the one robust debut from the 2 weak ones, but it surely doesn’t order the weak two accurately – Symbiotec had the thinnest retail ebook and nonetheless opened flat. The HNI cut up is the extra fascinating one. In Hy-Tech, small HNI bid tougher than large HNI (542.10x towards 332.38x); in Skyways and Symbiotec it was the opposite means spherical. Smaller cheques had been enthusiastic about precisely one among these three points, and that’s the one which listed effectively. Watching day-wise subscription standing through the challenge window enables you to see this construct up stay, as a substitute of studying it afterwards.

The quantity no person was

This one sat within the RHP the entire time, and obtained far much less consideration than the gray market quote.

Symbiotec’s challenge was virtually totally a suggestion on the market. Of ₹1,757 crore raised, solely ₹150 crore went to the corporate, for debt reimbursement and normal company functions. The different ₹1,607 crore went to promoting shareholders. Hy-Tech saved ₹60 crore of its ₹135.73 crore challenge – ₹30 crore for capital expenditure, ₹16 crore for repaying borrowings, and the remaining for normal functions.

In our view, this fresh-issue versus OFS cut up deserves much more consideration than it will get. It solutions a easy query: is the cash going into the enterprise, or into an current shareholder’s pocket? It is disclosed, it’s verifiable, and it doesn’t change in a single day. Three corporations show no rule, and OFS-heavy points have listed strongly many instances. But it’s a free query to ask earlier than you apply.

What to verify as a substitute of GMP

Both Skyways and Symbiotec are actual companies. Symbiotec holds a 36.2% share of world corticosteroid API volumes and 44.2% in steroidal-hormone APIs, from its base in Madhya Pradesh. Today was not a business-quality failure. It was a pricing and expectations failure. All of the under was out there earlier than you utilized, and none of it sits contained in the GMP.

• Profit development, not income dimension. Symbiotec’s FY25 income rose 5% to ₹751.6 crore, however revenue fell 3.3% to ₹96.8 crore (June 2025 quarter: ₹29.9 crore). Revenue up with revenue down is a margin query, and a flat itemizing is a minimum of per the market noticing.
• Category-wise demand, not the whole. Symbiotec’s worker quota was subscribed 15.41 instances towards retail at 12.96 instances. Employees bidding tougher than the general public is a small sign, however a free one.
• Where the contemporary cash goes. Capacity and capex have a really totally different future from debt reimbursement. Symbiotec’s administration mentioned on itemizing day that development ought to come from advanced injectables and fermentation CDMO, with the main capex for each already full – the corporate’s personal assertion, not our forecast, however one thing concrete to verify towards later outcomes.
• Valuation towards listed friends. Post-issue P/E versus the sector median is a ten-minute calculation from the RHP, and the step most individuals skip. Hy-Tech’s market capitalisation reached ₹682.94 crore on debut; whether or not that’s defensible towards its earnings is a separate query from whether or not it listed at a premium.
• Anchor lock-in dates. The 30-day and 90-day expiries are recognized provide occasions after itemizing. They are disclosed. They aren’t within the GMP.
• Your personal holding interval. GMP is a one-day quantity. If you aren’t promoting on day one, it’s answering a query you by no means requested.

Long-term traders often learn an RHP in a hard and fast order: enterprise mannequin, three-year financials, promoter holding after the difficulty, use of contemporary cash, the chance elements in full, and valuation towards friends. GMP, if used in any respect, comes final – as a sentiment studying, not a worth goal. Subscription knowledge belongs in the identical place, simply learn one layer deeper: watch which class is bidding, and when.